vs

Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and INSTEEL INDUSTRIES INC (IIIN). Click either name above to swap in a different company.

INSTEEL INDUSTRIES INC is the larger business by last-quarter revenue ($159.9M vs $83.5M, roughly 1.9× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 4.7%, a 2.1% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 23.3%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-2.2M).

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.

BLLN vs IIIN — Head-to-Head

Bigger by revenue
IIIN
IIIN
1.9× larger
IIIN
$159.9M
$83.5M
BLLN
Growing faster (revenue YoY)
BLLN
BLLN
+94.1% gap
BLLN
117.4%
23.3%
IIIN
Higher net margin
BLLN
BLLN
2.1% more per $
BLLN
6.8%
4.7%
IIIN
More free cash flow
BLLN
BLLN
$8.7M more FCF
BLLN
$6.5M
$-2.2M
IIIN

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BLLN
BLLN
IIIN
IIIN
Revenue
$83.5M
$159.9M
Net Profit
$5.7M
$7.6M
Gross Margin
69.9%
11.3%
Operating Margin
11.5%
6.0%
Net Margin
6.8%
4.7%
Revenue YoY
117.4%
23.3%
Net Profit YoY
138.3%
602.4%
EPS (diluted)
$0.10
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLLN
BLLN
IIIN
IIIN
Q4 25
$159.9M
Q3 25
$83.5M
$177.4M
Q2 25
$179.9M
Q1 25
$160.7M
Q4 24
$129.7M
Q3 24
$38.4M
$134.3M
Q2 24
$145.8M
Q1 24
$127.4M
Net Profit
BLLN
BLLN
IIIN
IIIN
Q4 25
$7.6M
Q3 25
$5.7M
$14.6M
Q2 25
$15.2M
Q1 25
$10.2M
Q4 24
$1.1M
Q3 24
$-14.9M
$4.7M
Q2 24
$6.6M
Q1 24
$6.9M
Gross Margin
BLLN
BLLN
IIIN
IIIN
Q4 25
11.3%
Q3 25
69.9%
16.1%
Q2 25
17.1%
Q1 25
15.3%
Q4 24
7.3%
Q3 24
52.6%
9.1%
Q2 24
10.6%
Q1 24
12.3%
Operating Margin
BLLN
BLLN
IIIN
IIIN
Q4 25
6.0%
Q3 25
11.5%
10.8%
Q2 25
11.0%
Q1 25
8.3%
Q4 24
1.1%
Q3 24
-32.9%
4.5%
Q2 24
6.0%
Q1 24
7.0%
Net Margin
BLLN
BLLN
IIIN
IIIN
Q4 25
4.7%
Q3 25
6.8%
8.2%
Q2 25
8.4%
Q1 25
6.4%
Q4 24
0.8%
Q3 24
-38.8%
3.5%
Q2 24
4.5%
Q1 24
5.4%
EPS (diluted)
BLLN
BLLN
IIIN
IIIN
Q4 25
$0.39
Q3 25
$0.10
$0.74
Q2 25
$0.78
Q1 25
$0.52
Q4 24
$0.06
Q3 24
$-1.47
$0.24
Q2 24
$0.34
Q1 24
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLLN
BLLN
IIIN
IIIN
Cash + ST InvestmentsLiquidity on hand
$195.2M
$15.6M
Total DebtLower is stronger
$55.0M
Stockholders' EquityBook value
$-239.5M
$358.8M
Total Assets
$327.5M
$456.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLLN
BLLN
IIIN
IIIN
Q4 25
$15.6M
Q3 25
$195.2M
$38.6M
Q2 25
$53.7M
Q1 25
$28.4M
Q4 24
$36.0M
Q3 24
$111.5M
Q2 24
$97.7M
Q1 24
$83.9M
Total Debt
BLLN
BLLN
IIIN
IIIN
Q4 25
Q3 25
$55.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BLLN
BLLN
IIIN
IIIN
Q4 25
$358.8M
Q3 25
$-239.5M
$371.5M
Q2 25
$356.2M
Q1 25
$341.4M
Q4 24
$331.6M
Q3 24
$-242.9M
$350.9M
Q2 24
$346.0M
Q1 24
$340.6M
Total Assets
BLLN
BLLN
IIIN
IIIN
Q4 25
$456.1M
Q3 25
$327.5M
$462.6M
Q2 25
$471.9M
Q1 25
$421.9M
Q4 24
$404.7M
Q3 24
$422.6M
Q2 24
$414.6M
Q1 24
$397.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLLN
BLLN
IIIN
IIIN
Operating Cash FlowLast quarter
$13.8M
$-701.0K
Free Cash FlowOCF − Capex
$6.5M
$-2.2M
FCF MarginFCF / Revenue
7.7%
-1.4%
Capex IntensityCapex / Revenue
8.8%
0.9%
Cash ConversionOCF / Net Profit
2.42×
-0.09×
TTM Free Cash FlowTrailing 4 quarters
$439.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLLN
BLLN
IIIN
IIIN
Q4 25
$-701.0K
Q3 25
$13.8M
$-17.0M
Q2 25
$28.5M
Q1 25
$-3.3M
Q4 24
$19.0M
Q3 24
$16.2M
Q2 24
$18.8M
Q1 24
$1.4M
Free Cash Flow
BLLN
BLLN
IIIN
IIIN
Q4 25
$-2.2M
Q3 25
$6.5M
$-18.7M
Q2 25
$26.9M
Q1 25
$-5.5M
Q4 24
$16.3M
Q3 24
$14.5M
Q2 24
$15.5M
Q1 24
$-580.0K
FCF Margin
BLLN
BLLN
IIIN
IIIN
Q4 25
-1.4%
Q3 25
7.7%
-10.6%
Q2 25
15.0%
Q1 25
-3.5%
Q4 24
12.6%
Q3 24
10.8%
Q2 24
10.7%
Q1 24
-0.5%
Capex Intensity
BLLN
BLLN
IIIN
IIIN
Q4 25
0.9%
Q3 25
8.8%
1.0%
Q2 25
0.9%
Q1 25
1.4%
Q4 24
2.1%
Q3 24
1.3%
Q2 24
2.2%
Q1 24
1.5%
Cash Conversion
BLLN
BLLN
IIIN
IIIN
Q4 25
-0.09×
Q3 25
2.42×
-1.17×
Q2 25
1.88×
Q1 25
-0.32×
Q4 24
17.56×
Q3 24
3.48×
Q2 24
2.86×
Q1 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLLN
BLLN

Prenatal$74.1M89%
Oncology$8.7M10%

IIIN
IIIN

Welded Wire Reinforcement$108.4M68%
PC Strand$51.6M32%

Related Comparisons